Literature DB >> 18983445

Decoding epithelial signals: critical role for the epidermal growth factor receptor in controlling intestinal transport function.

D F McCole1, K E Barrett.   

Abstract

The intestinal epithelium engages in bidirectional transport of fluid and electrolytes to subserve the physiological processes of nutrient digestion and absorption, as well as the elimination of wastes, without excessive losses of bodily fluids that would lead to dehydration. The overall processes of intestinal ion transport, which in turn drive the secretion or absorption of water, are accordingly carefully regulated. We and others have identified the epidermal growth factor receptor (EGFr) as a critical regulator of mammalian intestinal ion transport. In this article, we focus on our studies that have uncovered the intricate signalling mechanisms downstream of EGFr that regulate both chloride secretion and sodium absorption by colonocytes. Emphasis will be placed on the EGFr-associated regulatory pathways that dictate the precise outcome to receptor activation in response to signals that may seem, on their face, to be quite similar if not identical. The concepts to be discussed underlie the ability of the intestinal epithelium to utilize a limited set of signalling effectors to produce a variety of outcomes suitable for varying physiological and pathophysiological demands. Our findings therefore are relevant not only to basic biological principles, but also may ultimately point to new therapeutic targets in intestinal diseases where ion transport is abnormal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983445      PMCID: PMC2630365          DOI: 10.1111/j.1748-1716.2008.01929.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  47 in total

1.  Actin modifies Ca2+ block of epithelial Na+ channels in planar lipid bilayers.

Authors:  B K Berdiev; R Latorre; D J Benos; I I Ismailov
Journal:  Biophys J       Date:  2001-05       Impact factor: 4.033

2.  Insulin-stimulated trafficking of ENaC in renal cells requires PI 3-kinase activity.

Authors:  Bonnie L Blazer-Yost; Michail A Esterman; Chris J Vlahos
Journal:  Am J Physiol Cell Physiol       Date:  2003-02-26       Impact factor: 4.249

Review 3.  SGK1 regulation of epithelial sodium transport.

Authors:  David Pearce
Journal:  Cell Physiol Biochem       Date:  2003

Review 4.  Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors.

Authors:  Bernard C Rossier; Sylvain Pradervand; Laurent Schild; Edith Hummler
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

5.  Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular Ca2+, PYK-2, and p60(src).

Authors:  S J Keely; S O Calandrella; K E Barrett
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

6.  A role for protein kinase cepsilon in the inhibitory effect of epidermal growth factor on calcium-stimulated chloride secretion in human colonic epithelial cells.

Authors:  J Y Chow; J M Uribe; K E Barrett
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

Review 7.  Diarrhea in ulcerative colitis. The role of altered colonic sodium transport.

Authors:  E Greig; G I Sandle
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 8.  The ErbB receptor tyrosine family as signal integrators.

Authors:  N E Hynes; K Horsch; M A Olayioye; A Badache
Journal:  Endocr Relat Cancer       Date:  2001-09       Impact factor: 5.678

Review 9.  Concerted action of ENaC, Nedd4-2, and Sgk1 in transepithelial Na(+) transport.

Authors:  Elena Kamynina; Olivier Staub
Journal:  Am J Physiol Renal Physiol       Date:  2002-09

10.  Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha.

Authors:  Declan F McCole; Stephen J Keely; Robert J Coffey; Kim E Barrett
Journal:  J Biol Chem       Date:  2002-08-28       Impact factor: 5.157

View more
  8 in total

1.  Epidermal growth factor receptor inhibits colitis-associated cancer in mice.

Authors:  Philip E Dubé; Fang Yan; Shivesh Punit; Nandini Girish; Steven J McElroy; M Kay Washington; D Brent Polk
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

Review 2.  Anlotinib as a molecular targeted therapy for tumors.

Authors:  Yi Gao; Pengfei Liu; Ruihua Shi
Journal:  Oncol Lett       Date:  2020-05-28       Impact factor: 2.967

3.  Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea.

Authors:  Joanne M Bowen; Bronwen J Mayo; Erin Plews; Emma Bateman; Andrea M Stringer; Frances M Boyle; John W Finnie; Dorothy M K Keefe
Journal:  Cancer Biol Ther       Date:  2012-08-16       Impact factor: 4.742

4.  Epidermal growth factor chronically upregulates Ca(2+)-dependent Cl(-) conductance and TMEM16A expression in intestinal epithelial cells.

Authors:  Magdalena S Mroz; Stephen J Keely
Journal:  J Physiol       Date:  2012-02-20       Impact factor: 5.182

5.  Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrhea.

Authors:  Tianying Duan; Onur Cil; Jay R Thiagarajah; Alan S Verkman
Journal:  JCI Insight       Date:  2019-02-21

Review 6.  Development of the rat model of lapatinib-induced diarrhoea.

Authors:  Joanne M Bowen
Journal:  Scientifica (Cairo)       Date:  2014-07-07

Review 7.  Pathophysiology of IBD associated diarrhea.

Authors:  Arivarasu N Anbazhagan; Shubha Priyamvada; Waddah A Alrefai; Pradeep K Dudeja
Journal:  Tissue Barriers       Date:  2018-05-08

8.  Potentiation of calcium-activated chloride secretion and barrier dysfunction may underlie EGF receptor tyrosine kinase inhibitor-induced diarrhea.

Authors:  Younjoo Kim; Andrew Quach; Soumita Das; Kim E Barrett
Journal:  Physiol Rep       Date:  2020-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.